Novartis Investigative Site is a clinical research site located in Port Charlotte, Florida, United States 33952.
Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.
Novartis Investigative Site has participated in 13 clinical trials with 1 currently active.
Therapeutic areas: Relapsing Multiple Sclerosis, Major Depressive Disorder, Relapsing Remitting Multiple Sclerosis.
Sponsors: Novartis Pharmaceuticals, Novartis.
Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Novartis Investigative Site has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Novartis Investigative Site has 13 clinical trials on record, with 1 currently active. Their work covers Relapsing Multiple Sclerosis, Major Depressive Disorder, Relapsing Remitting Multiple Sclerosis.
Yes — Novartis Investigative Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.